- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01591408
EEG Biofeedback Therapy as an Adjunct Treatment for PTSD
Placebo-controlled Study of EEG Biofeedback Therapy as an Adjunct Treatment for PTSD, Evaluating Symptoms and EEG Dynamics
The proposed study, "Placebo-controlled study of EEG biofeedback therapy as an adjunct treatment for PTSD, evaluating symptoms and EEG dynamics", will investigate the brain dynamics associated with PTSD symptom reduction associated with EEG biofeedback therapy or sham EEG biofeedback in addition to treatment as usual at the Naval Medical Center, San Diego (NMCSD) OASIS program.
EEG biofeedback treatment protocols for PTSD and other disorders have been developed and honed by private practice clinicians over the past 25 years, during which EEG biofeedback has become an increasingly popular adjunct therapy.
The reported success of EEG biofeedback as a non-drug intervention with lasting efficacy warrants a clinical study investigating not only symptom reduction, but also the underlying neurobiological mechanism. To this end, we propose a study using high density EEG recordings before and after treatment for PTSD symptoms to determine which brain activities correlate with reported symptom changes.
The proposed study could expand treatment alternatives for servicemen with PTSD. If EEG biofeedback is shown to improve symptom reduction over the placebo controlled condition, it would offer a non-pharmacological intervention that would avoid undesirable side effects, and accelerate recovery compared with the current standard of care.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
EEG biofeedback is an emerging alternative approach to treating PTSD, for which there is still insufficient evidence to assume unequivocal clinical utility. However, a 1991 report showed PTSD symptom reduction in 14 subjects receiving EEG biofeedback, as compared to 13 subjects receiving traditional treatment (Peniston, 1991), and a recent case study of 2 PTSD patients receiving EEG biofeedback therapy also showed reduce symptom severity using a newer protocol and device (Othmer, 2009). Another recent study focused on the anxiety symptoms of PTSD and showed that EEG biofeedback significantly reduced anxiety compared to subjects not receiving treatment (Walker, 2009).
EEG biofeedback has also been explored as a treatment for non-PTSD related anxiety disorders, with results showing significant changes in reported anxiety correlated with increased or decreased alpha-frequency (~8-12 Hz) power (Hardt, 1978). Similarly, alpha-frequency EEG biofeedback has been shown to reduce anxiety and to reduce heart rate reactivity to a stressor after 8 sessions of EEG biofeedback training (Rice, 1993). While EEG biofeedback has been shown to significantly change EEG power dynamics (Egner, 2004), it is still unclear if and how EEG biofeedback can effect long-term and complex changes in cognitive and/or emotional functioning.
Some attention has been given to other types of biofeedback for the treatment for PTSD, such as heart rate variability (HRV) biofeedback, which may be relevant in understanding the background of biofeedback with respect to PTSD treatment. While one study reported no difference in symptom reduction between treatment as usual and treatment as usual plus HRV biofeedback (Lande, 2010), a handful of other studies have reported significant associations between HRV changes and PTSD symptoms. Specifically, increased HRV was significantly correlated with PTSD symptom reduction, which was more effective with respiratory sinus arrhythmia (RSA) (which affects HRV) biofeedback than with progressive muscle relaxation (Zucker, 2009). Furthermore, combat-related PTSD subjects showed lower resting HRV than controls, but training with HRV biofeedback increased PTSD subjects' HRV and simultaneously decreased their PTSD symptoms (Tan, 2011). Finally, a quantitative EEG study showed that an acute session of RSA biofeedback was associated with an increase in alpha-band power and reduced higher frequency beta-band power, suggesting a neural impact of RSA training and HRV regulation (Sherlin, 2010).
Summary The proposed study of EEG biofeedback at the OASIS program will not only address the clinical efficacy, but also the brain activations associated with specific symptoms of PTSD through collection of high-density EEG data before and after EEG biofeedback treatment. These data will help elucidate the neural correlates of PTSD symptom expression as well as address the potential efficacy of EEG biofeedback therapy as an adjunct treatment for PTSD-like symptoms.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
California
-
San Diego, California, États-Unis
- OASIS PTSD program
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Male,
- active military,
- participating in PTSD program at NMCSD
Exclusion Criteria:
- Seizure disorder.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: EEG biofeedback
Subjects will receive EEG biofeedback according to their own brain rhythms
|
EEG data is collected from the scalp.
Data is decomposed in real time and a portion of the signal is fed back to the subject via a vibrating stuffed animal and visual cues.
Autres noms:
|
Comparateur factice: sham EEG biofeedback
Subjects will receive feedback according to someone else's brain rhythms collected during a different session.
|
EEG data is collected from the scalp.
Data is decomposed in real time and a portion of the signal is fed back to the subject via a vibrating stuffed animal and visual cues.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Improved Symptom Ratings
Délai: 4 weeks
|
Will test whether subjects receiving real EEG biofeedback report decreased anxiety and irritability relative to subjects receiving sham biofeedback.
The scale for each rating was a 0-10, with 0 meaning "not at all" and 10 being "extremely" anxious/irritable.
|
4 weeks
|
Collaborateurs et enquêteurs
Collaborateurs
Les enquêteurs
- Chercheur principal: Julie A Onton, PhD, Naval Health Research Center
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- NMCSD.2012.0042
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur SSPT
-
Oregon Health and Science UniversityInscription sur invitation
-
Life UniversitySuspendu
-
Direction Centrale du Service de Santé des ArméesRecrutementLa dépression | Anxiété | PtsdFrance
-
Skane University HospitalRecrutement
-
Ohio State UniversityActif, ne recrute pasIdéation suicidaire | Suicide, Tentative | PtsdÉtats-Unis
-
David Lynch FoundationPas encore de recrutementIdéation suicidaire | Symptômes dépressifs | Consommation d'alcool, non précisée | Ptsd
-
University of Texas at AustinActif, ne recrute pasLa dépression | Troubles anxieux | Dépression bipolaire | PtsdÉtats-Unis
-
Psychiatric Research Unit, Region Zealand, DenmarkComplétéDépression | Troubles anxieux | Trouble de la personnalité limite | PtsdDanemark
-
University of WashingtonNational Institute of Nursing Research (NINR); East Carolina UniversityPas encore de recrutementUtilisateur de défibrillateur implantable | Réaction au stress | Ptsd | La gestion du stress | Théorie cognitive socialeÉtats-Unis
-
VA Palo Alto Health Care SystemComplété
Essais cliniques sur EEG biofeedback
-
Stanford UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)RecrutementEn bonne santé | Lombalgie chroniqueÉtats-Unis
-
University of Massachusetts, WorcesterNational Center for Complementary and Integrative Health (NCCIH)Complété
-
VA Office of Research and DevelopmentInscription sur invitation
-
Radboud University Medical CenterComplété
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)ComplétéCancer de la tête et du couÉtats-Unis, Chine
-
McMaster UniversityComplétéCrises non convulsivesCanada
-
Centre Hospitalier Universitaire de BesanconPlateforme NeuraxessRecrutementRégulation émotionnelle | Prise de risqueFrance
-
Kuopio University HospitalComplétéÉtat de mal épileptique | Altération de l'état mental | SaisieFinlande
-
Andrea Rossetti, MDComplétéComa | Résultat, fatal | EEG avec des fréquences anormalement lentes | EEG avec anomalies périodiquesSuisse
-
Kuopio University HospitalRésilié